Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 117.5 GBX Market Closed
Market Cap: 99.2m GBX
Have any thoughts about
Diaceutics PLC?
Write Note

Diaceutics PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Diaceutics PLC
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Diaceutics PLC
LSE:DXRX
Revenue
ÂŁ23.7m
CAGR 3-Years
23%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Oxford Nanopore Technologies PLC
LSE:ONT
Revenue
ÂŁ169.7m
CAGR 3-Years
14%
CAGR 5-Years
39%
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Revenue
ÂŁ272k
CAGR 3-Years
-30%
CAGR 5-Years
-40%
CAGR 10-Years
-26%
Ergomed PLC
LSE:ERGO
Revenue
ÂŁ152.1m
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Revenue
ÂŁ24.7m
CAGR 3-Years
N/A
CAGR 5-Years
28%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Revenue
ÂŁ64.4m
CAGR 3-Years
22%
CAGR 5-Years
64%
CAGR 10-Years
41%
No Stocks Found

Diaceutics PLC
Glance View

Market Cap
99.5m GBX
Industry
Life Sciences Tools & Services

Diaceutics Plc engages in the provision of data, data analytics and implementation services. The company is headquartered in Belfast, Northern Ireland. The company went IPO on 2019-03-21. The principal activity of the Company is data analytics and implementation services. The firm is engaged in research and development activities in drug development science, testing data and software platform development. The firm's implementation services include test standardization, test quality assessment, laboratory tech support and others. The firm has established a range of products and outsourced advisory services, which help its pharma clients to optimize and deliver their marketing and implementation strategies for companion diagnostics. The firm provides the pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX - The Diagnostic Network. DXRX is the diagnostic commercialization platform for precision medicine, integrating multiple pipelines of diagnostic testing data from a global network of laboratories.

DXRX Intrinsic Value
155.79 GBX
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Diaceutics PLC's Revenue?
Revenue
23.7m GBP

Based on the financial report for Dec 31, 2023, Diaceutics PLC's Revenue amounts to 23.7m GBP.

What is Diaceutics PLC's Revenue growth rate?
Revenue CAGR 5Y
18%

Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Diaceutics PLC have been 23% over the past three years , 18% over the past five years .

Back to Top